NANOG Recombinant Monoclonal Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Production

NANOG Recombinant Monoclonal Antibodies are genetically engineered to bind specifically to the NANOG protein, a transcription factor essential for maintaining the undifferentiated state of pluripotent stem cells . Unlike conventional monoclonal antibodies (mAbs) derived from hybridoma fusion, recombinant antibodies are synthesized in vitro using plasmid vectors and host cell systems (e.g., HEK293 or Expi293F cells) .

Key Production Steps:

  1. Cloning: Antibody variable region DNA is isolated from immunized animals or antibody libraries .

  2. Expression: DNA is inserted into plasmid vectors and transfected into host cells for antibody production .

  3. Purification: Antibodies are purified via affinity chromatography (e.g., Protein A/G) .

This method eliminates the need for animal immunization and allows for precise engineering of antibody properties (e.g., isotype, epitope targeting) .

Table 1: Comparative Overview of NANOG Recombinant Monoclonal Antibodies

Antibody (Clone)Host SpeciesImmunogenApplicationsRecommended DilutionSource
MA5-32198 (SC05-70)RabbitRecombinant human NANOGWB, IHC, ICC/IFWB: 1:500–1:1000; IHC: 1:50–100
MA1-017 (23D2-3C6)MouseHuman embryonal carcinomaWB, IHCWB: 0.2–0.5 µg/mL; IHC: ≤20 µg/mL
ab109250 (EPR20272)RabbitSynthetic peptide (human)WB, IHC, ICC/IF, FlowWB: 1:500–1:1000; IHC: 1:50–100
PCRP-NANOGP1-2D8MouseRecombinant NANOG (aa1–127)IP, WB, IHC, ICCWB: 0.2–0.5 µg/mL; IHC: 2–5 µg/mL
CSB-RA032801A0HURabbitSynthetic peptide (human)FCFC: 1:50–1:200

Critical Properties:

  • Epitope Specificity: Targets diverse regions, including the homeodomain (critical for DNA binding) and N-terminal/C-terminal activation domains .

  • Species Reactivity: Primarily human; some cross-react with mouse (e.g., eBioMLC-51) .

  • Purity: >90% via SDS-PAGE or HPLC .

Research Applications

NANOG Recombinant Monoclonal Antibodies are pivotal in studying stem cell biology, cancer, and regenerative medicine.

Table 2: Applications and Validation

ApplicationAntibody ExampleValidationReference
Western BlotMA1-017, MA5-32198Detects ~35–38 kDa band in embryonal carcinoma (NTERA) and iPSC lysates .
Immunohistochemistryab109250, MA5-32198Stains nuclear NANOG in pluripotent cells; distinguishes undifferentiated ESCs.
Flow CytometryCSB-RA032801A0HUQuantifies NANOG+ populations in iPSCs or cancer cells .
ImmunoprecipitationPCRP-NANOGP1-2D8Pulls down NANOG complexes for interaction studies (e.g., SMAD1 in BMP signaling) .

Key Research Findings:

  • Pluripotency Maintenance: NANOG overexpression sustains iPSC self-renewal and blocks differentiation .

  • Cancer Association: Overexpressed in germ cell tumors, embryonal carcinomas, and breast cancer, enabling its use as a diagnostic marker .

  • Therapeutic Potential: Used in generating virus-free iPSCs for regenerative therapies .

Advantages Over Traditional Antibodies

Recombinant antibodies offer distinct advantages, as summarized below:

AttributeRecombinant AntibodyTraditional Antibody
ConsistencyLot-to-lot uniformity due to genetic standardizationVariable affinity/epitope specificity
SpecificityEngineered to minimize cross-reactivityPotential off-target binding
Animal UseNo immunization requiredRequires animal immunization
ScalabilityHigh-throughput productionLimited by hybridoma cell viability
CustomizationFc engineering (e.g., Fc-tag removal, bispecific)Fixed isotype and format

These features make recombinant antibodies ideal for high-throughput screens and reproducible longitudinal studies .

Product Specs

Buffer
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Description

The NANOG recombinant monoclonal antibody is produced using in vitro expression systems. This involves cloning NANOG antibody DNA sequences from immunoreactive rabbits. The immunogen used is a synthesized peptide derived from the human NANOG protein. The NANOG antibody genes are then inserted into plasmid vectors, which are transfected into host cells to enable antibody expression. Following expression, the NANOG recombinant monoclonal antibody undergoes affinity-chromatography purification. It is rigorously tested for functionality in ELISA and FC applications, demonstrating its reactivity with the human NANOG protein.

NANOG protein plays a crucial role in regulating pluripotency and self-renewal in stem cells, particularly in embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Its functions are essential for early embryonic development, stem cell maintenance, and cell fate determination.

Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days after receiving it. Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery times.
Synonyms
Homeobox protein NANOG (Homeobox transcription factor Nanog) (hNanog), NANOG
Target Names
Uniprot No.

Target Background

Function
NANOG is a transcription regulator involved in inner cell mass and embryonic stem (ES) cell proliferation and self-renewal. It imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. NANOG blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. It can act as a transcriptional activator or repressor. NANOG binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. It binds to the POU5F1/OCT4 promoter. NANOG can autorepress its expression in differentiating (ES) cells: it binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, NANOG promotes cells to enter into S phase and proliferation.
Gene References Into Functions
  1. The critical roles of NANOG and its pseudogene NANOGP8 in cancer progression make the association of these genes with exosomes significant, and may allow for exosomal NANOG to function as a powerful diagnostic biomarker. Variations in NANOG/NANOGP8 gene sequences in exosomal DNA includes an insertion into the 3' UTR. PMID: 29787607
  2. A higher expression of the pluripotency factor NANOG. PMID: 29845283
  3. The interaction of Nanog with the AR signaling axis might induce or contribute to Ovarian cancer stem cells regulation. In addition, androgen might promote stemness characteristics in ovarian cancer cells by activating the Nanog promoter PMID: 29716628
  4. The results show that Nanog expression was related to HBsAg, differentiation, and TNM stage in hepatocellular carcinoma (HCC). Nanog may be an unfavorable prognostic biomarker for HCC. PMID: 29198990
  5. NANOG might be a potential biomarker for early diagnosis of urothelial carcinoma of the bladder. PMID: 29279584
  6. These results demonstrate that analysis of IHC expression patterns of MK and NANOG in pretreatment biopsy specimens during the work-up period can provide a more definitive prognosis prediction for each oral squamous cell carcinoma (OSCC) patient that can help clinicians to develop a more precise individual treatment modality. PMID: 29113102
  7. Chicken egg-white extracts promote OCT4 and NANOG expression and telomeres growth in 293T cells. PMID: 28838341
  8. Rectal tumor tissue OCT4 (p<0.001), SOX2 (p=0.003), and NANOG (p<0.001) expressions were higher than those in adjacent tissue. PMID: 29214774
  9. Data show that lung adenocarcinoma SPC-A1 cell differentiated by a two-stage induction (TSI) method lost stem cell characteristics, including absent expression of OCT4 and Nanog. PMID: 27588392
  10. our data suggest that 3D culture increases the expression of Nanog through the relaxation of actin cytoskeleton, which mediates reduced Suv39h1 and H3K9me3 levels. PMID: 28276635
  11. results show that NANOG could reverse the effects of stem cell senescence and restore the myogenic differentiation potential of senescent MSCs. PMID: 28125933
  12. MACC1-induced tumor progression in colorectal cancer acts, at least in part, via the newly discovered MACC1/Nanog/Oct4 axis. PMID: 26758557
  13. RNAi-mediated silencing of NANOG in SKOV-3 reversed the expression of mesenchymal cell markers and restored expression of E-cadherin. Susceptibility to cisplatin increased in SKOV-3 cells on down-regulating NANOG and reversible results were obtained in Moody cells post-overexpression of NANOG. PMID: 27884977
  14. NANOG enabled reactivation of the ROCK and Transforming Growth Factor (TGF)-beta pathways-both of which were impaired in senescent cells-leading to ACTIN polymerization, MRTF-A translocation into the nucleus and serum response factor (SRF)-dependent myogenic gene expression. PMID: 27350449
  15. High NANOG expression is associated with brain neoplasms. PMID: 28933914
  16. Super-enhancers at the Nanog locus differentially regulate neighboring pluripotency-associated genes, in particular, DPPA3. PMID: 27681417
  17. our data reveal that SATB2 in alveolar bone mesenchymal stem cells (AB-BMSCs) associates with their age-related properties, and prevents AB-BMSCs senescence via maintaining Nanog expression. PMID: 27632702
  18. High NANOG expression is associated with Multidrug Resistance in breast and cervical cancer. PMID: 28716899
  19. miR-612 has a suppressive role on hepatocellular carcinoma cell stemness via Sp1/Nanog signaling pathway. PMID: 27685621
  20. These data reveal an overexpression of NANOG and other markers of pluripotency and stemness in meningiomas. PMID: 28345785
  21. The NANOG deficiency affected multiple genes, particularly, supressed drug-resistance via down-regulated ABCG2 in Eca109 cells, and caused G1 arrest by down-regulated cyclin D1 (CCND1) expression. PMID: 28601640
  22. Endogenous Plastic Somatic (ePS) cells in a latent state, i.e. lacking SOX2, OCT3/4 and NANOG (SON) expression, in non-diseased breast specimens through immunohistochemical analysis of previously identified ePS-specific biomarkers (CD73(+), EpCAM(+) and CD90(-)). PMID: 27705752
  23. Data suggest that C-terminal truncated hepatitis B virus X protein (HBx-DeltaC1) enhances liver cancer stem cell (CSC) properties through Stat3/Nanog cascade, and insight for the therapeutic intervention for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). PMID: 28186991
  24. Nanog directly repressed transcription of the miR-200c and miR-200b genes in colon cancer cells, inducing epithelial-mesenchymal transformation. PMID: 28163188
  25. LGR5-expressing fraction of CD54+ cells represents gastric cancer CSCs, in which LGR5 is closely associated with stemness and EMT core genes PMID: 28033430
  26. Data show that Nanog homebox (NANOG) but not sex-determining region Y-box2 (SOX2) and octamer-binding protein 4 (OCT4) expression was overexpressed in the endometrium of women with intrauterine adhesion (IUA). PMID: 28253866
  27. The NANOG transcription was significantly upregulated by ETV4 overexpression. PMID: 28412366
  28. Collectively, these findings demonstrate a novel role of YBX1 in maintaining the stemness of CSCs and metastasis, unveiling YBX1 as promising therapeutic target for NSCLC treatments. PMID: 28400280
  29. the early response of pluripotency genes OCT4 and NANOG to the differentiation-inducing stimuli is mediated by dynamic changes in chromatin marks, while DNA methylation is acquired in the later stages of neurogenesis. PMID: 28601081
  30. USP21 specifically regulates the Lys48-linked polyubiquitination and stability of NANOG PMID: 27956178
  31. To our knowledge, this is the first report on lineage reprogramming of TILs using protein stem cell transcription factors delivered directly to the nucleus. PMID: 27084449
  32. Nanog expression is a prognostic biomarkers for triple-negative breast cancer PMID: 27300169
  33. Stat3 was correlated with NANOG-mediated EMT. PMID: 26801672
  34. miR-760 was proved to be functional associated with NANOG via regulating its expression. PMID: 27133070
  35. SIRT-1 and NANOG are high correlated biological markers for diagnosis and prognosis follow up in patients with adenocarcinoma. PMID: 27540973
  36. renal cell carcinoma patients with low Nanog and Oct4 expressions in tumor tissues had significantly higher survival rates (p < 0.05). High Nanog and Oct4 expressions may be potential therapeutic targets. PMID: 26631537
  37. ANOG was regulated by extracellular IGF signaling pathway via STAT3 phosphorylation in colorectal cancer (CRC). This coincides with that IGF receptor IGF-1R is often increasing expressed in malignant metastasis colon cancer. Taken together, our data define the crucial functions of IGF/STAT3/NANOG/Slug signaling axis in the progression of CRC PMID: 26840943
  38. Nanog is a positive regulator of cervical cancer dedifferentiation. PMID: 26936116
  39. Data show that long intergenic non-protein coding RNA ROR may act as a competitive endogenous RNAs (ceRNAs), effectively becoming a sink for microRBA miR-145, thereby activating the derepression of core transcription factors Nanog. PMID: 26636540
  40. ALKBH5 overexpression decreased NANOG mRNA methylation, increased NANOG levels, and increased the percentage of BCSCs, phenocopying the effect of hypoxia PMID: 27001847
  41. Expression levels of OCT4, SOX2, and NANOG were evaluated by immunohistochemistry with tissue microarray slides of 436 OSCC, 362 corresponding tumor-adjacent normal (CTAN) tissues, and 71 normal uvula epithelium tissues. PMID: 26211876
  42. Nanog possesses important function in BCSC. PMID: 26339994
  43. Our study provides new insight into the function of DPPA5 and NANOG regulation in human pluripotent stem cell . PMID: 26661329
  44. the available data demonstrate that NANOG is strictly involved in the process of carcinogenesis and is a potential prognostic marker of malignant tumors. PMID: 26618281
  45. the disruption of Nanog expression results in less proliferation, invasiveness, migration, more chemosensitivity and reversal of EMT in HepG2 cells, by which Nanog plays crucial roles in influencing the malignant phenotype of HepG2 cells. PMID: 26676719
  46. The promoter activity of Nanog and Oct4 were upregulated, and beta-catenin was observed to bind to these promoters during H. pylori infection, while a Wnt/beta-catenin inhibitor suppressed promoter activity and binding. PMID: 26940070
  47. ectopic expression of Oct-4 gene in hAFMSCs with high self-renewal ability could upregulate Nanog and Sox-2 gene expression PMID: 25385323
  48. Nanog is an oncogene with multiple roles in promoting tumorigenesis and metastasis PMID: 26073077
  49. The positive correlation among Oct-4, Nanog, and beta-catenin suggests their coordinated role in maintaining proliferation in oral carcinoma cells. PMID: 24700702
  50. Oct3/4 and Nanog represent probable CSC markers in HNSCC, which contribute to the development of DNM in part by enhancing cell motility and invasiveness. PMID: 26483189

Show More

Hide All

Database Links

HGNC: 20857

OMIM: 607937

KEGG: hsa:79923

STRING: 9606.ENSP00000229307

UniGene: Hs.635882

Protein Families
Nanog homeobox family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in testicular carcinoma and derived germ cell tumors (at protein level). Expressed in fetal gonads, ovary and testis. Also expressed in ovary teratocarcinoma cell line and testicular embryonic carcinoma. Not expressed in many somatic organs and

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.